| Catalog No. | Size | Price (USD) |
| 13089-RP01-100 | 100 µL | $147.96 |
| 13089-RP01-200 | 200 µL | $251.64 |
| 13089-RP01-400 | 400 µL | $355.32 |
General Information
| Product name | Anti-IL-19 Antibody, Rabbit Polyclonal |
| Validated applications | ELISA (FAQ Protocol) |
| Species reactivity | Reacts with: Human |
| Specificity | Human IL-19 |
| Immunogen | Recombinant Human IL19 / Interleukin-19 protein (Catalog#13089-H08H) |
| Preparation | Produced in rabbits immunized with purified, recombinant Human IL19 / Interleukin-19 (rh IL19; Catalog#13089-H08H; AAF06663.1; Met1-Ala177). Total IgG was purified by Protein A affinity chromatography. |
| Source | Polyclonal Rabbit IgG |
| Purification | Protein A |
| Formulation | 0.2 μm filtered solution in PBS |
| Conjugate | Unconjugated |
| Form | Liquid |
| Shipping | This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Storage | This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles. |
Synonyms: Anti-IL-10C Antibody; Anti-IL-19 Antibody; Anti-MDA1 Antibody; Anti-NG.1 Antibody; Anti-ZMDA1 Antibody
Background Information
| Full Name | interleukin 19 |
| Description | The molecular features at the IL19 locus may modestly alter the establishment of HIV-1 infection. Interleukin (IL) 19, IL-20, and IL-24 belong to the IL-10 cytokine family and have been identified to play a role in the regulation of epidermal functions and inflammation. The expression of IL19 in biopsies of patients with active ulcerative colitis was increased compared with patients with quiescent ulcerative colitis and that colitis was attenuated in IL-19-deficient mice. The disruption of the epithelial barrier with dextran sodium sulfate leads to increased IL-19 expression. Attenuated colitis in IL-19-deficient animals was associated with reduced numbers of IL-6-producing macrophages in the inflamed colonic lamina propria. Microbial-driven expression of IL-19 by intestinal macrophages may contribute to the pathogenesis of inflammatory bowel disease. |
